*4.3.4 Age*

Interaction between the advanced glycation end-products (AGE) with its receptor (RAGE) is known to have pro-inflammatory consequences. Pharmacological inhibition of RAGE signalling led to a significant decrease in retinal capillary degeneration and other early lesion of DR in animal models [29].
